Roche sees Dx unit outperform market, but hit by strong Swiss franc
This article was originally published in Clinica
Roche's diagnostics division looks to be holding strong as the group's nine-month financial results revealed that the unit's top-line continues to grow faster than the global IVD market.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.